Occupational Therapists in Saint George, UT Accepting Medicare

8 Occupational Therapists found. Showing 1 - 8

Madelynn Bryan, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 168 N 100 E, Saint George, UT 84770 Phone: 435-200-4844

Scott Munson, O.T. Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1380 E Medical Center Dr, Saint George, UT 84790 Phone: 435-251-1000    Fax: 435-688-5114

Dawson Flake, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 162 N 400 E Ste A105, Saint George, UT 84770 Phone: 435-275-8911    Fax: 435-200-9442

Russell Wood Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1032 E 100 S, Saint George, UT 84770 Phone: 435-628-0488    Fax: 435-628-7362

Rebecca Hopkins, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1380 E Medical Center Dr, Saint George, UT 84790 Phone: 435-688-5223    Fax: 435-688-5514

Adaptive Home Modification And Design, Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2144 W Rivers Edge Ln, Saint George, UT 84770 Phone: 435-313-2295

Sage Fowler, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1380 E Medical Center Dr, Saint George, UT 84790 Phone: 435-251-1000

Megan Bernardino Nava, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1380 E Medical Center Dr, Saint George, UT 84790 Phone: 435-251-1000

News Archive

Ocera Therapeutics presents Phase 2 proof-of-concept study results of AST-120 in non-constipating IBS

Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.

Bioalma introduces customized portal for biomedical community

Bioalma today announced mynovo|seek, the industry's first customized portal for users that enables a more personalized user interface. In response to user feedback, mynovo|seek allows for saved searches and search results, chronicled search history, the ability to create email alerts on new published research and the ability to export citations from Medline - in full text or from grants – all in one place.

Researchers discover 'common set of dysregulated miRNAs in murine lupus models'

Potentially impacting future diagnosis and treatment of lupus, an immune illness affecting more than 5 million people worldwide, researchers at the Virginia-Maryland Regional College of Veterinary Medicine at Virginia Tech have likely uncovered where the breakdown in the body's lymphocyte molecular regulatory machinery is occurring.

Aziyo Biologics introduces new CanGaroo Bio Envelope for use with S-ICDs

Aziyo Biologics, Inc., a fully integrated regenerative medicine company, today announced the launch of a new CanGaroo Bio Envelope specifically for use with subcutaneous implantable cardioverter-defibrillators (S-ICDs).

Read more Medical News

› Verified 3 days ago